Bristol-Myers
Squibb Company (NYSE:BMY) will take part in Leerink Partners
Immuno-Oncology Roundtable Conference on Thursday, September 29, 2016,
in New York. Fouad Namouni, senior vice president, Head of Oncology,
will answer questions about the company at 3:00 p.m. EDT.
Investors and the general public are invited to listen to a live webcast
of the session at http://investor.bms.com.
An archived edition of the session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com or
follow us on LinkedIn, Twitter,
YouTube
and Facebook.
Bristol-Myers Squibb Company Media:Ken Dominski, 609-252-5251 ken.dominski@bms.com or Investors:Tim Power, 609-252-7509 timothy.power@bms.com orBill Szablewski, 609-252-5894 william.szablewski@bms.com